(Press-News.org) Earlier this summer, members of the National Center for Supercomputing Applications traveled to Alaska as part of their continued work with the Permafrost Discovery Gateway, a project led by the Woodwell Climate Research Center using artificial intelligence (AI) and machine learning (ML) in tracking Arctic permafrost thaw.
NCSA’s Associate Director for Software Kenton McHenry and Research Software Engineer Todd Nicholson visited Fairbanks, Alaska along with 12 Google.org fellows to see first hand the melting permafrost and the impacts to those that live there.
“I have seen the artifacts of melting permafrost for years through the satellite images we work with, yet I was shocked to see things firsthand,” said McHenry. “What should be flat terrain was filled with 6-feet-deep ravines, the borders of these ice-wedge polygons. The trees at 45 or greater degree angles. The sinkholes in the University of Fairbanks parking lot.”
Seeing the permafrost research tunnel was a great experience. It shows just how significant permafrost is to the Arctic, how much it affects the land and the environment. Hearing from people about how permafrost thaw affects them in their day-to-day life lets you know how important the topic is.
Todd Nicholson, NCSA Research Software Engineer
Funded by a $5 million grant from Google.org, the Permafrost Discover Gateway, with further Google.org fellowship support, is developing and expanding a new, open-access resource that will use satellite data and AI technology to make it possible to track Arctic permafrost thaw regularly for the first time ever. This potentially game-changing resource for climate science will utilize advances in AI/ML technology to streamline the data analysis process and make it easier to rapidly identify patterns and trends in permafrost thaw datasets that will be essential to informing climate mitigation and adaptation strategies for city planners.
“We are excited to be working with Google.org to improve and extend the tools and data pipelines initially developed for the Permafrost Discovery Gateway to new use cases,” said NCSA Lead Research Software Engineer Luigi Marini after the award was announced. “Closing the time gap between remote sensing data products becoming available and permafrost data products being published, such as the pan-Arctic sub-meter scale ice-wedge polygon dataset developed by Chandi Witharana and team, will hopefully help scientists and stakeholders better understand permafrost thawing at the pan-Arctic scale. We also hope to generalize some of the technologies and tools being developed so that more scientists can leverage this work to develop new permafrost-related data pipelines.”
But NCSA’s trip didn’t just center around software and science. The Arctic adventure included underground tours, an ice hotel, team activities and more.
“On our way to the permafrost cave we stopped by to see a portion of the Trans-Alaska oil pipeline,” McHenry said. “A few of us were amazed that it was actually built on top of permafrost, and to prevent its foundation from melting, it had thousands of passive refrigeration units along it to pump the winter cold into the ground to help prevent the permafrost from thawing in the summer.”
During the same period, the project hosted 12 Google software engineers who assisted in the Arctic research. Through a program partnering with research projects like the Permafrost Discovery Gateway, Google staff apply for opportunities to work on scientific research as a change of pace from their normal work.
“Several of the fellows told us how much they really enjoyed this experience working within science and would like more opportunities to do so,” McHenry said.
ABOUT NCSA
The National Center for Supercomputing Applications at the University of Illinois Urbana-Champaign provides supercomputing, expertise and advanced digital resources for the nation’s science enterprise. At NCSA, University of Illinois faculty, staff, students and collaborators from around the globe use innovative resources to address research challenges for the benefit of science and society. NCSA has been assisting many of the world’s industry giants for over 35 years by bringing industry, researchers and students together to solve grand challenges at rapid speed and scale.
END
NCSA, Google work together in Alaska as part of Permafrost Discovery Gateway
2024-09-30
ELSE PRESS RELEASES FROM THIS DATE:
The world’s top cancer experts, entrepreneurs, and advocates to join the National Foundation for Cancer Research on October 18th, 2024, in Washington, DC, at the National Press Club
2024-09-30
Rockville, MD. (September 30, 2024) – The 2024 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, co-hosted by the National Foundation for Cancer Research (NFCR) and AIM-HI Accelerator Fund, will be held on October 18th at the National Press Club in Washington, DC.
This is the one event each year where key leaders from the entire cancer research and patient care ecosystem come together under one roof to share critical discoveries and ideas from all areas of cancer research, drug development, and patient care. This is where many innovative ...
Cardiac myosin inhibition in heart failure with normal and supranormal ejection fraction
2024-09-30
About The Study: In an open-label trial in patients with heart failure with preserved ejection fraction with left ventricular ejection fraction of 60% or greater, mavacamten, a cardiac myosin inhibitor, was associated with improvements in biomarkers of cardiac wall stress and injury, with no sustained reductions in left ventricular ejection fraction observed.
Corresponding Authors: To contact the corresponding authors, email Sanjiv J. Shah, MD, (sanjiv.shah@northwestern.edu) and Scott ...
Amy Vandiver, MD, PhD, of UCLA receives the 2024 Sagol Network GerOmic Award for Junior Faculty
2024-09-30
NEW YORK — The American Federation for Aging Research (AFAR) is pleased to announce the recipient of the 2024 Sagol Network GerOmic Award for Junior Faculty: Amy Vandiver, MD, PhD, Clinical Instructor Clinician-Investigator Track, University of California Los Angeles. Established in 2020, the Sagol Network GerOmic Award for Junior Faculty is a one- to two-year award given to junior faculty (MDs and PhDs) to conduct aging-related Omics (GerOmics) research.
Omics is a rapidly evolving, multi-disciplinary, and emerging field that encompasses genomics, epigenomics, transcriptomics, ...
Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction
2024-09-30
WASHINGTON, September 30, 2024 — An accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstruction following a mastectomy, new research shows. Findings of the large, phase III RT CHARM trial (Alliance A221505) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
While radiation therapy following mastectomy to remove breast cancer is known to improve survival rates for certain patients who are at higher risk of recurrence, RT CHARM is the first multi-institutional international study to show that a shorter course ...
IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer
2024-09-30
WASHINGTON, September 30, 2024 — People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy — proton beam therapy or intensity modulated radiation therapy (IMRT) — achieved equally high rates of tumor control with no differences in patient-reported quality of life, according to a first-of-its-kind phase III clinical trial comparing the two technologies. Findings of the PARTIQoL trial will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
“We tested two contemporary, advanced forms of external ...
Timing matters when adding immunotherapy to chemoradiation for patients with limited-stage small cell lung cancer
2024-09-30
WASHINGTON, September 30, 2024 — People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds. The results suggest that the timing of when immunotherapy is given plays a key role in its ability to extend survival. Findings of the multi-institutional phase III trial, which also found that twice-daily radiation treatments offer greater survival benefits than once-daily treatment, will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
The ...
Existing standard chemoradiation superior to deintensification approaches for HPV-related oropharyngeal cancer
2024-09-30
WASHINGTON, September 30, 2024 — Researchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal cancer to prevent long-term side effects halted a large, randomized phase II/III trial after patients in the control arm reached a record high, two-year progression-free survival rate of 98%. De-intensified treatments involving a lower radiation dose and immunotherapy in place of chemotherapy did not perform as well as the more rigorous chemoradiation approach. Findings of the NRG Oncology HN005 trial will be presented today at the American Society for Radiation Oncology (ASTRO) Annual ...
CAR-T safe and effective on an outpatient basis in community hospitals
2024-09-30
(WASHINGTON – September 30, 2024) In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outpatient basis, patients with relapsed or refractory large B-cell lymphoma (LBCL) responded well to treatment with few serious side effects, according to results published today in Blood Advances.
LBCL is a cancer affecting B lymphocytes, a type of white blood cell. It can progress rapidly and is fatal if untreated, although most forms of LBCL respond well to standard ...
City of Hope to present leading-edge radiotherapy treatments for people with lung, genitourinary and blood cancers at the American Society for Radiation Oncology Annual Meeting
2024-09-30
LOS ANGELES — City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S. News & World Report, is part of today’s press conference program at the American Society for Radiation Oncology (ASTRO) Annual Meeting, where a renowned City of Hope radiation oncologist will present phase 3 clinical trial data showing that people with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time. The results suggest that the timing of when immunotherapy is given plays a key role in its ...
A new and unique fusion reactor comes together with PPPL's contributions
2024-09-30
Like atoms coming together to release their power, fusion researchers worldwide are joining forces to solve the world’s energy crisis. Harnessing the power of fusing plasma as a reliable energy source for the power grid is no easy task, requiring global contributions.
The Princeton Plasma Physics Laboratory (PPPL) — a U.S. national laboratory funded by the Department of Energy (DOE) — is leading several efforts on this front, including collaborating on the design and development of a new fusion device at the University of Seville in Spain. The SMall Aspect Ratio Tokamak (SMART) strongly ...